Indication
Idiopathic Infantile Hypercalcemia
1 clinical trial
1 product
Clinical trial
Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Inactivating Mutations in the CYP24A1 GeneStatus: Recruiting, Estimated PCD: 2026-12-01
Product
Rifampin